Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine Effects on Ticagrelor in STEMI
NCT02913469Phase 4Unknown
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Dec 2014
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of morphine and metoclopramide in ST-segment elevation myocardial infarction (STEMI) (4 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Platelet Reactivity Index at 2 hours. Status: unknown.
02
Drugs
morphinemetoclopramide
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02913469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913469.